A Monoclonal antibody against Human GSTA3 (clone 1F11). The antibodies are raised in Mouse and are from clone 1F11. This antibody is applicable in WB and IHC-P, E
PD-L1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC) (1). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC (2). PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells (3). This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. PD-L1 also functions as an immune checkpoint protein, and multiple anti-PD-L1 antibodies are currently in phase II and III clinical trials, with one antibody already approved for the treatment of cancer (4).
A Monoclonal antibody against Human KIAA0101 (monoclonal) (M01). The antibodies are raised in mouse and are from clone 3C11-1F11. This antibody is applicable in WB, IHC and IF, E
A Monoclonal antibody against Human GSTA3 (clone 1F11). The antibodies are raised in Mouse and are from clone 1F11. This antibody is applicable in WB and IHC-P, E